Seraphina Therapeutics
Founded 2017 · 14 employees on LinkedIn · 2 known investors
Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age. The company focuses on evidence-based nutritional science for consumer wellness.
Investors · 2
Frequently asked questions
- What does Seraphina Therapeutics do?
- Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age. The company focuses on evidence-based nutritional science for consumer wellness.
- Who are Seraphina Therapeutics's investors?
- Seraphina Therapeutics's investors include 1315 Capital, BioBrit.